Published in Gastroenterology on March 02, 2008
The combination of ribavirin and peginterferon is superior to peginterferon and placebo for children and adolescents with chronic hepatitis C. Gastroenterology (2010) 2.48
Knockdown of autophagy enhances the innate immune response in hepatitis C virus-infected hepatocytes. Hepatology (2011) 1.47
Spontaneous clearance of hepatitis C virus in vertically infected children. Eur J Pediatr (2011) 1.47
Symptomatic and pathophysiologic predictors of hepatitis C virus progression in pediatric patients. Pediatr Infect Dis J (2009) 1.40
Performance of the AST-to-platelet ratio index as a noninvasive marker of fibrosis in pediatric patients with chronic viral hepatitis. J Pediatr Gastroenterol Nutr (2010) 1.35
Integrating phylodynamics and epidemiology to estimate transmission diversity in viral epidemics. PLoS Comput Biol (2013) 1.07
Indian National Association for Study of the Liver (INASL) Guidance for Antiviral Therapy Against HCV Infection: Update 2016. J Clin Exp Hepatol (2016) 1.02
Pegylated interferon for chronic hepatitis C in children affects growth and body composition: results from the pediatric study of hepatitis C (PEDS-C) trial. Hepatology (2012) 1.01
Hepatitis C virus core protein augments androgen receptor-mediated signaling. J Virol (2008) 0.98
Hepatitis B and C in pregnancy: a review and recommendations for care. J Perinatol (2014) 0.91
Managing pediatric hepatitis C: current and emerging treatment options. Ther Clin Risk Manag (2009) 0.90
Risk factors for hepatitis C virus acquisition and predictors of persistence among Egyptian children. Liver Int (2011) 0.90
Vertical transmission of hepatitis C virus: Current knowledge and perspectives. World J Hepatol (2014) 0.89
Relationship between aspartate aminotransferase-to-platelet ratio index and carotid intima-media thickness in obese adolescents with non-alcoholic fatty liver disease. J Clin Res Pediatr Endocrinol (2013) 0.82
Autoimmunity and extrahepatic manifestations in treatment-naïve children with chronic hepatitis C virus infection. Clin Dev Immunol (2012) 0.82
Managing HCV infection in pediatric age group: suggested recommendations. Saudi J Gastroenterol (2010) 0.80
Vertically acquired hepatitis C virus infection: Correlates of transmission and disease progression. World J Gastroenterol (2016) 0.79
Natural history of vertically acquired HCV infection and associated autoimmune phenomena. Eur J Pediatr (2014) 0.79
Current treatment options and response rates in children with chronic hepatitis C. World J Gastroenterol (2012) 0.79
Comparative analysis of rs12979860 SNP of the IFNL3 gene in children with hepatitis C and ethnic matched controls using 1000 Genomes Project data. PLoS One (2014) 0.79
Population pharmacokinetics of peginterferon alfa-2b in pediatric patients with chronic hepatitis C. Eur J Clin Pharmacol (2013) 0.79
Hepatitis C Viral Infection in Children: Updated Review. Pediatr Gastroenterol Hepatol Nutr (2016) 0.79
Is liver biopsy still needed in children with chronic viral hepatitis? World J Gastroenterol (2015) 0.78
What's new in hepatitis C virus infections in children? World J Gastroenterol (2015) 0.78
Cirrhosis in children and adolescents: An overview. World J Hepatol (2015) 0.78
Spontaneous clearance of hepatitis C virus in vertically infected children: any clue for treatment? Eur J Pediatr (2011) 0.77
Chronic hepatitis C virus infection in children and adolescents: Epidemiology, natural history, and assessment of the safety and efficacy of combination therapy. Adolesc Health Med Ther (2010) 0.77
Modelling CD4 T Cell Recovery in Hepatitis C and HIV Co-infected Children Receiving Antiretroviral Therapy. Pediatr Infect Dis J (2017) 0.75
Hepatitis C Co-Infection and CD4+ T Cell Recovery in HIV-Infected Children Receiving Anti-Retroviral Therapy. Pediatr Infect Dis J (2016) 0.75
Treating hepatitis C virus in children: time for a new paradigm. J Virus Erad (2015) 0.75
Pegylated interferon alfa and ribavirin for children with chronic hepatitis C. World J Gastroenterol (2013) 0.75
Hepatitis C in the pediatric population: transmission, natural history, treatment and liver transplantation. World J Gastroenterol (2014) 0.75
Single Clinical Practice's Report of Testing Initiation, Antibody Clearance, and Transmission of Hepatitis C Virus (HCV) in Infants of Chronically HCV-Infected Mothers. Open Forum Infect Dis (2016) 0.75
Polymorphisms in the IFNL3/IL28B gene and hepatitis C: from adults to children. World J Gastroenterol (2014) 0.75
Hepatitis B and C. Pediatr Clin North Am (2017) 0.75
Vertical genotype 1 HCV infection treated successfully in the second year of life: a case report. Med Sci Monit (2012) 0.75
CD4(+) and CD8(+) T Cell Activation in Children with Hepatitis C. J Pediatr (2015) 0.75
Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis. Gastroenterology (2012) 5.75
Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C. Hepatology (2010) 5.24
Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease. J Hepatol (2003) 5.17
Introduction of gluten, HLA status, and the risk of celiac disease in children. N Engl J Med (2014) 4.64
Field-practice study of sorafenib therapy for hepatocellular carcinoma: a prospective multicenter study in Italy. Hepatology (2011) 4.60
Effect of thalidomide on clinical remission in children and adolescents with refractory Crohn disease: a randomized clinical trial. JAMA (2013) 3.67
Industrial, not fruit fructose intake is associated with the severity of liver fibrosis in genotype 1 chronic hepatitis C patients. J Hepatol (2013) 3.20
Carotid atherosclerosis and chronic hepatitis C: a prospective study of risk associations. Hepatology (2012) 3.04
Retinol-binding protein 4: a new marker of virus-induced steatosis in patients infected with hepatitis c virus genotype 1. Hepatology (2008) 2.91
Multiple phenotypes in phosphoglucomutase 1 deficiency. N Engl J Med (2014) 2.62
Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C. J Hepatol (2006) 2.61
Cost-effectiveness of sofosbuvir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C. Hepatology (2014) 2.47
SAFE biopsy: a validated method for large-scale staging of liver fibrosis in chronic hepatitis C. Hepatology (2009) 2.45
Microbial translocation predicts disease progression of HIV-infected antiretroviral-naive patients with high CD4+ cell count. AIDS (2011) 2.45
Peginterferon alfa-2b plus ribavirin for naïve patients with genotype 1 chronic hepatitis C: a randomized controlled trial. J Hepatol (2004) 2.30
Community‐acquired bacteremic pneumococcal pneumonia in children: diagnosis and serotyping by real‐time polymerase chain reaction using blood samples. Clin Infect Dis (2010) 2.22
NAFLD in children: a prospective clinical-pathological study and effect of lifestyle advice. Hepatology (2006) 2.06
Long-term outcome of bone mineral density in children who underwent a successful liver transplantation. Transplantation (2004) 2.04
Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trial. Hepatology (2008) 2.02
High sustained virologic response rates in children with chronic hepatitis C receiving peginterferon alfa-2b plus ribavirin. J Hepatol (2010) 2.01
A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma. Gastroenterology (2009) 1.90
Re-evaluation of the diagnostic criteria for Wilson disease in children with mild liver disease. Hepatology (2010) 1.87
A seven-gene signature (cirrhosis risk score) predicts liver fibrosis progression in patients with initially mild chronic hepatitis C. Hepatology (2009) 1.78
Lack of progressive hepatic fibrosis during long-term therapy with deferiprone in subjects with transfusion-dependent beta-thalassemia. Blood (2002) 1.77
Early menopause is associated with lack of response to antiviral therapy in women with chronic hepatitis C. Gastroenterology (2010) 1.76
Molecular detection methods and serotyping performed directly on clinical samples improve diagnostic sensitivity and reveal increased incidence of invasive disease by Streptococcus pneumoniae in Italian children. J Med Microbiol (2008) 1.71
Performance of ELF serum markers in predicting fibrosis stage in pediatric non-alcoholic fatty liver disease. Gastroenterology (2008) 1.71
Acute surgical abdomen as presenting manifestation of Kawasaki disease. J Pediatr (2003) 1.70
Liver transplantation for HCV cirrhosis: improved survival in recent years and increased severity of recurrent disease in female recipients: results of a long term retrospective study. Liver Transpl (2007) 1.68
Maternal drug use is a preeminent risk factor for mother-to-child hepatitis C virus transmission: results from a multicenter study of 1372 mother-infant pairs. J Infect Dis (2002) 1.68
Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis. Hepatology (2008) 1.66
Non-organ-specific autoantibodies in children with chronic hepatitis C: clinical significance and impact on interferon treatment. Clin Infect Dis (2003) 1.65
Beyond "cirrhosis": a proposal from the International Liver Pathology Study Group. Am J Clin Pathol (2012) 1.65
A meta-analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma. Hepatology (2010) 1.64
Genotype-phenotype correlation in Italian children with Wilson's disease. J Hepatol (2008) 1.63
Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation. Liver Transpl (2009) 1.60
Realtime PCR is more sensitive than multiplex PCR for diagnosis and serotyping in children with culture negative pneumococcal invasive disease. PLoS One (2010) 1.59
Insulin resistance and necroinflammation drives ductular reaction and epithelial-mesenchymal transition in chronic hepatitis C. Gut (2010) 1.59
Metabolic, hormonal, oxidative, and inflammatory factors in pediatric obesity-related liver disease. J Pediatr (2005) 1.58
Intrauterine growth retardation, insulin resistance, and nonalcoholic fatty liver disease in children. Diabetes Care (2007) 1.58
Influence of steroids on HCV recurrence after liver transplantation: A prospective study. J Hepatol (2007) 1.56
An updated follow-up of chronic hepatitis C after three decades of observation in pediatric patients cured of malignancy. Pediatr Blood Cancer (2010) 1.55
Sustained Epstein-Barr virus detection in paediatric liver transplantation. Insights into the occurrence of late PTLD. Liver Transpl (2007) 1.52
Natural history of chronic HBV carriers in northern Italy: morbidity and mortality after 30 years. Gastroenterology (2004) 1.52
The homeostasis model assessment of the insulin resistance score is not predictive of a sustained virological response in chronic hepatitis C patients. Liver Int (2010) 1.51
Reduced serum hepcidin levels in patients with chronic hepatitis C. J Hepatol (2009) 1.48
Transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis of individual patient data. Gastroenterology (2007) 1.48
IL28B and PNPLA3 polymorphisms affect histological liver damage in patients with non-alcoholic fatty liver disease. J Hepatol (2012) 1.48
Liver steatosis in children with chronic hepatitis C. Am J Gastroenterol (2006) 1.46
Fecal calprotectin in clinical practice: a noninvasive screening tool for patients with chronic diarrhea. J Clin Gastroenterol (2012) 1.44
Management of chronic hepatitis C in childhood: the impact of therapy in the clinical practice during the first 2 decades. Dig Liver Dis (2010) 1.42
Seven novel mutations of the UGT1A1 gene in patients with unconjugated hyperbilirubinemia. Haematologica (2007) 1.40
Aseptic meningitis in neonatal varicella complicated by Escherichia coil sepsis. Eur J Pediatr (2004) 1.39
Sequential algorithms combining non-invasive markers and biopsy for the assessment of liver fibrosis in chronic hepatitis B. World J Gastroenterol (2007) 1.34
Probiotics reduce the inflammatory response induced by a high-fat diet in the liver of young rats. J Nutr (2009) 1.34
Epidemiology and clinical features of Mycoplasma pneumoniae infection in children. Respir Med (2008) 1.31
Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection. Am J Gastroenterol (2008) 1.28
Correlation of serum TNF-alpha levels and histologic liver injury scores in pediatric nonalcoholic fatty liver disease. Am J Clin Pathol (2007) 1.28
The impact of radiotherapy on survival in resectable gastric carcinoma: a meta-analysis of literature data. Cancer Treat Rev (2007) 1.28
Chronic hepatitis B in children after e antigen seroclearance: final report of a 29-year longitudinal study. Hepatology (2006) 1.27
Analysis of liver repair mechanisms in Alagille syndrome and biliary atresia reveals a role for notch signaling. Am J Pathol (2007) 1.26
When and how to treat acute hepatitis C? J Hepatol (2003) 1.24
Liver biopsy interpretation for causes of late liver allograft dysfunction. Hepatology (2006) 1.24
Duodenal bulb biopsies in celiac disease: a multicenter study. J Pediatr Gastroenterol Nutr (2008) 1.24
Universal childhood immunisation against Streptococcus pneumoniae: the five-year experience of Liguria Region, Italy. Vaccine (2009) 1.23
Chronic hepatitis C virus infection in childhood: clinical patterns and evolution in 224 white children. Clin Infect Dis (2003) 1.18
Pharmacological interventions for nonalcoholic fatty liver disease in adults and in children: a systematic review. J Pediatr Gastroenterol Nutr (2009) 1.17
Performance of commercial blood tests for the diagnosis of latent tuberculosis infection in children and adolescents. Pediatrics (2009) 1.14
Determinants of alpha-fetoprotein levels in patients with hepatocellular carcinoma: implications for its clinical use. Cancer (2014) 1.13
Systemic efficacy of combined suicide/cytokine gene therapy in a murine model of hepatocellular carcinoma. J Hepatol (2005) 1.13
Isolated hepatocyte transplantation for Crigler-Najjar syndrome type 1. Cell Transplant (2005) 1.12
Oxidative stress inhibits IFN-alpha-induced antiviral gene expression by blocking the JAK-STAT pathway. J Hepatol (2006) 1.12
Fibrosis in chronic hepatitis C acquired in infancy: is it only a matter of time? Am J Gastroenterol (2003) 1.12
Clinical features and progression of perinatally acquired hepatitis C virus infection. J Med Virol (2003) 1.12
Metformin use in children with nonalcoholic fatty liver disease: an open-label, 24-month, observational pilot study. Clin Ther (2008) 1.11